The future of glioblastoma therapy: synergism of standard of care and immunotherapy.

Cancers (Basel) · 2014 · PMC4276952 · PMID 25268164

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

found that low-dose metronomic TMZ administration in a rat glioma model resulted in decreased circulating Tregs and reduced tumor progression, though the latter did not reach statistical significance [ 203 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.